Resmed (RSMDF) EBT Margin (2009 - 2026)
Resmed's (RSMDF) quarterly EBT Margin came in at 32.4% in Q2 2026, down 158.0% on a YoY basis from 55.86% in Q2 2025, and down 7.68% quarter-over-quarter from 35.09% in Q1 2026.
Powered by 
Analysis
Resmed (RSMDF) EBT Margin (2009 - 2026) Analysis & Trends
Resmed (RSMDF) has reported EBT Margin for 18 consecutive years, with 32.4% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT Margin fell 158.0% year-over-year to 32.4%; the trailing twelve-month figure through Jun 2026 stood at 33.95% (up 135.0% YoY), and the FY2026 full-year result was 33.95%, up 135.0% from the prior year.
- EBT Margin retreated to 32.4% in Q2 2026 per RSMDF's latest filing, from 35.09% in the prior quarter.
- Across five years, EBT Margin topped out at 35.09% in Q1 2026 and bottomed at 22.31% in Q4 2023.
- Historically, EBT Margin has averaged 29.47% across 5 years, with a median of 30.28% in 2024.
- The sharpest annual moves came in 2023 and 2024: EBT Margin sank 416 bps in 2023, then jumped 1032 bps in 2024.
- Over 5 years, EBT Margin stood at 26.48% in 2022, then decreased by 16 bps to 22.31% in 2023, then soared by 46 bps to 32.63% in 2024, then rose by 7 bps to 34.87% in 2025, then fell by 7 bps to 32.4% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 32.4%, 35.09%, and 34.87% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.06 Bn | 178.46 Bn | 7.27 Bn | 12.10% |
| 2 | Intuitive Surgical | 124.29 Bn | 119.08 Bn | 1.96 Bn | 36.46% |
| 3 | Medtronic | 118.26 Bn | 109.44 Bn | 6.34 Bn | 18.13% |
| 4 | Stryker | 104.56 Bn | 101.08 Bn | 4.50 Bn | 23.74% |
| 5 | Boston Scientific | 66.33 Bn | 65.79 Bn | 3.85 Bn | 19.48% |
| 6 | Edwards Lifesciences | 49.62 Bn | 45.37 Bn | 1.35 Bn | 29.86% |
| 7 | Alcon | 33.94 Bn | 32.48 Bn | 1.68 Bn | -1.65% |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 24.27% |
| 9 | Steris | 21.14 Bn | 20.65 Bn | 684.20 Mn | 18.32% |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn | 32.40% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.40% |
| Mar 31, 2026 | 35.09% |
| Dec 31, 2025 | 34.87% |
| Sep 30, 2025 | 33.45% |
| Jun 30, 2025 | 33.98% |
| Mar 31, 2025 | 32.34% |
| Dec 31, 2024 | 32.63% |
| Sep 30, 2024 | 31.32% |
| Jun 30, 2024 | 29.25% |
| Mar 31, 2024 | 31.36% |
| Dec 31, 2023 | 22.31% |
| Sep 30, 2023 | 24.69% |
| Jun 30, 2023 | 24.67% |
| Mar 31, 2023 | 25.91% |
| Dec 31, 2022 | 26.48% |
| Sep 30, 2022 | 27.55% |
| Jun 30, 2022 | 26.03% |
| Mar 31, 2022 | 26.18% |
| Dec 31, 2021 | 26.52% |
| Sep 30, 2021 | 28.63% |